Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Download features.
Download gene features.
Norway rat (Rattus norvegicus) is a species of rodent in the family Muridae that is widely used as an experimental model organism.
Taxonomy ID: 10116
Rattus norvegicus stromal interaction molecule 2 (Stim2), mRNA
4,868 bp linear mRNA
Protein PubMed Taxonomy
KR 1020240045300-A/6: FACTOR XII (F12) IRNA COMPOSITIONS AND METHODS OF USE THEREOF
2,128 bp linear DNA
Taxonomy
KR 1020240045300-A/5: FACTOR XII (F12) IRNA COMPOSITIONS AND METHODS OF USE THEREOF
KR 1020240036041-A/54: METABOLIC DISORDER-ASSOCIATED TARGET GENE IRNA COMPOSITIONS AND METHODS OF USE THEREOF
2,022 bp linear DNA
KR 1020240036041-A/53: METABOLIC DISORDER-ASSOCIATED TARGET GENE IRNA COMPOSITIONS AND METHODS OF USE THEREOF
KR 1020240036041-A/46: METABOLIC DISORDER-ASSOCIATED TARGET GENE IRNA COMPOSITIONS AND METHODS OF USE THEREOF
5,368 bp linear DNA
KR 1020240036041-A/45: METABOLIC DISORDER-ASSOCIATED TARGET GENE IRNA COMPOSITIONS AND METHODS OF USE THEREOF
KR 1020240036041-A/34: METABOLIC DISORDER-ASSOCIATED TARGET GENE IRNA COMPOSITIONS AND METHODS OF USE THEREOF
2,025 bp linear DNA
KR 1020240036041-A/33: METABOLIC DISORDER-ASSOCIATED TARGET GENE IRNA COMPOSITIONS AND METHODS OF USE THEREOF
KR 1020240036041-A/22: METABOLIC DISORDER-ASSOCIATED TARGET GENE IRNA COMPOSITIONS AND METHODS OF USE THEREOF
1,899 bp linear DNA
KR 1020240036041-A/21: METABOLIC DISORDER-ASSOCIATED TARGET GENE IRNA COMPOSITIONS AND METHODS OF USE THEREOF
KR 1020240036041-A/6: METABOLIC DISORDER-ASSOCIATED TARGET GENE IRNA COMPOSITIONS AND METHODS OF USE THEREOF
1,053 bp linear DNA
KR 1020240036041-A/5: METABOLIC DISORDER-ASSOCIATED TARGET GENE IRNA COMPOSITIONS AND METHODS OF USE THEREOF
KR 1020240038103-A/48: COMPOSITIONS AND METHODS FOR THE TREATMENT OF HER2/NEU OVER-EXPRESSING TUMORS
929 bp linear DNA
KR 1020240038103-A/47: COMPOSITIONS AND METHODS FOR THE TREATMENT OF HER2/NEU OVER-EXPRESSING TUMORS
618 bp linear DNA
KR 1020240038103-A/46: COMPOSITIONS AND METHODS FOR THE TREATMENT OF HER2/NEU OVER-EXPRESSING TUMORS
360 bp linear DNA
KR 1020240038103-A/45: COMPOSITIONS AND METHODS FOR THE TREATMENT OF HER2/NEU OVER-EXPRESSING TUMORS
3,716 bp linear DNA
KR 1020240033237-A/8: LEUCINE-RICH REPEAT KINASE 2 (LRRK2) IRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOF
7,581 bp linear DNA
KR 1020240033237-A/7: LEUCINE-RICH REPEAT KINASE 2 (LRRK2) IRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOF
KR 1020240042004-A/8: TRANSTHYRETIN (TTR) IRNA COMPOSITIONS AND METHODS OF USE THEREOF
595 bp linear DNA
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on